Dashboard
Manage Tickers

EPR EPR PROPERTIES

NYSE eprkc.com


$ 49.01 $ 0.35 (0.71 %)    

Friday, 31-Oct-2025 16:30:02 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 49.02
$ 48.87
$ 48.75 x 101
$ 49.90 x 5
$ 48.33 - $ 49.34
$ 40.18 - $ 59.92
1,644,717
na
3.73B
$ 0.74
$ 21.27
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-30-2025 09-30-2025 10-Q
2 07-31-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 02-27-2025 01-01-1970 10-K
5 10-31-2024 09-30-2024 10-Q
6 08-01-2024 06-30-2024 10-Q
7 05-02-2024 03-31-2024 10-Q
8 02-29-2024 12-31-2023 10-K
9 10-26-2023 09-30-2023 10-Q
10 08-03-2023 06-30-2023 10-Q
11 04-27-2023 03-31-2023 10-Q
12 02-23-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-02-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 02-23-2022 12-31-2021 10-K
17 11-04-2021 09-30-2021 10-Q
18 07-28-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 02-25-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-11-2020 03-31-2020 10-Q
24 02-25-2020 12-31-2019 10-K
25 10-30-2019 09-30-2019 10-Q
26 08-01-2019 06-30-2019 10-Q
27 04-30-2019 03-31-2019 10-Q
28 02-28-2019 12-31-2018 10-K
29 10-30-2018 09-30-2018 10-Q
30 07-31-2018 06-30-2018 10-Q
31 05-09-2018 03-31-2018 10-Q
32 03-01-2018 12-31-2017 10-K
33 11-09-2017 09-30-2017 10-Q
34 08-04-2017 06-30-2017 10-Q
35 05-03-2017 03-31-2017 10-Q
36 03-01-2017 12-31-2016 10-K
37 11-03-2016 09-30-2016 10-Q
38 08-04-2016 06-30-2016 10-Q
39 04-29-2016 03-31-2016 10-Q
40 02-25-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

epr-props-narrows-fy2025-ffo-guidance-from-500-516-to-505-513-vs-508-est
EPR Props Narrows FY2025 FFO Guidance from...
10/29/2025 20:17:18

EPR Props (NYSE:EPR) narrows FY2025 FFO guidance from $5.00-$5.16 to $5.05-$5.13 vs $5.08 analyst estimate..

epr-props-q3-ffo-139-beats-133-estimate-sales-182306m-beat-181785m-estimate
EPR Props Q3 FFO $1.39 Beats $1.33 Estimat...
10/29/2025 20:16:42

EPR Props (NYSE:EPR) reported quarterly earnings of $1.39 per share which beat the analyst consensus estimate of $1.33 by 4.35 ...

earnings-scheduled-for-october-29-2025
Earnings Scheduled For October 29, 2025
10/29/2025 11:11:56

jp-morgan-maintains-overweight-on-epr-props-raises-price-target-to-65
JP Morgan Maintains Overweight on EPR Prop...
09/12/2025 10:16:11

JP Morgan analyst Anthony Paolone maintains EPR Props (NYSE:EPR) with a Overweight and raises the price target from $56 to $65.

a-glimpse-into-the-expert-outlook-on-epr-props-through-8-analysts
A Glimpse Into The Expert Outlook On EPR P...
09/11/2025 13:01:19

wells-fargo-upgrades-epr-props-to-equal-weight-raises-price-target-to-56
Wells Fargo Upgrades EPR Props to Equal-We...
09/11/2025 11:52:19

Wells Fargo analyst John Kilichowski upgrades EPR Props (NYSE:EPR) from Underweight to Equal-Weight and raises the price tar...

eupraxia-pharmaceuticals--announces-data-from-resolve-trial-of-ep-104gi-in-eosinophilic-esophagitis-at-12-months-23-of-cohort-5-patients-remained-in-clinical-remission
Eupraxia Pharmaceuticals Announces Data F...
09/02/2025 12:06:10

wells-fargo-maintains-underweight-on-epr-props-raises-price-target-to-54
Wells Fargo Maintains Underweight on EPR P...
08/27/2025 14:06:34

Wells Fargo analyst John Kilichowski maintains EPR Props (NYSE:EPR) with a Underweight and raises the price target from $53 ...

this-epr-properties-analyst-is-no-longer-bullish-here-are-top-2-downgrades-for-tuesday
This EPR Properties Analyst Is No Longer B...
08/19/2025 13:47:28

keybanc-downgrades-epr-props-to-sector-weight
Keybanc Downgrades EPR Props to Sector Weight
08/19/2025 11:24:57

Keybanc analyst Todd Thomas downgrades EPR Props (NYSE:EPR) from Overweight to Sector Weight.

top-3-real-estate-stocks-that-could-blast-off-this-month
Top 3 Real Estate Stocks That Could Blast ...
08/15/2025 15:53:58

ubs-maintains-neutral-on-epr-props-lowers-price-target-to-54
UBS Maintains Neutral on EPR Props, Lowers...
08/15/2025 14:18:14

UBS analyst Michael Goldsmith maintains EPR Props (NYSE:EPR) with a Neutral and lowers the price target from $62 to $54.

where-epr-props-stands-with-analysts
Where EPR Props Stands With Analysts
08/12/2025 12:00:22

raymond-james-maintains-strong-buy-on-epr-props-raises-price-target-to-62
Raymond James Maintains Strong Buy on EPR ...
08/12/2025 11:30:33

Raymond James analyst RJ Milligan maintains EPR Props (NYSE:EPR) with a Strong Buy and raises the price target from $57 to $62.

forecasting-the-future-9-analyst-projections-for-epr-props
Forecasting The Future: 9 Analyst Projecti...
08/04/2025 14:01:06

rbc-capital-downgrades-epr-props-to-sector-perform-maintains-price-target-to-58
RBC Capital Downgrades EPR Props to Sector...
08/04/2025 13:53:43

RBC Capital analyst Michael Carroll downgrades EPR Props (NYSE:EPR) from Outperform to Sector Perform and maintains the pric...

top-3-real-estate-stocks-that-may-rocket-higher-in-august
Top 3 Real Estate Stocks That May Rocket H...
08/01/2025 12:39:06

stifel-maintains-buy-on-epr-props-raises-price-target-to-655
Stifel Maintains Buy on EPR Props, Raises ...
07/31/2025 15:52:11

Stifel analyst Simon Yarmak maintains EPR Props (NYSE:EPR) with a Buy and raises the price target from $65 to $65.5.

epr-props-affirms-fy2025-ffo-guidance-of-500-516-vs-507-est
EPR Props Affirms FY2025 FFO Guidance of $...
07/30/2025 20:18:21

epr-props-q2-ffo-126-inline-sales-178068m-beat-174443m-estimate
EPR Props Q2 FFO $1.26, Inline, Sales $178...
07/30/2025 20:17:23

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION